| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥209.5B | ¥182.3B | +14.9% |
| Operating Income | ¥57.5B | ¥45.6B | +26.0% |
| Ordinary Income | ¥60.5B | ¥46.8B | +29.2% |
| Net Income | ¥57.7B | ¥35.0B | +64.9% |
| ROE | 18.9% | 13.0% | - |
FY2025 consolidated results showed strong performance with Revenue of 209.5B yen (+14.9% YoY), Operating Income of 57.5B yen (+26.0% YoY), Ordinary Income of 60.5B yen (+29.2% YoY), and Net Income of 57.7B yen (+64.9% YoY). The company maintained a high gross profit margin of 62.0% while controlling SG&A expenses at 34.5% of revenue, resulting in an operating margin expansion to 27.4%. Non-operating income contributed 3.2B yen, primarily from foreign exchange gains of 2.1B yen. Extraordinary income of 5.7B yen further boosted net income, driving the significant 64.9% YoY increase. The company's financial position strengthened with total assets reaching 364.2B yen and equity of 304.7B yen, maintaining an equity ratio of 83.7%. Cash and deposits stood at 103.5B yen, providing substantial liquidity. The full-year forecast projects revenue of 225.0B yen (+7.4% YoY) and operating income of 65.0B yen (+13.1% YoY), indicating continued growth momentum.
Revenue growth of 14.9% to 209.5B yen was driven by solid performance across all geographic segments. Japan segment generated 135.2B yen in external revenue (64.5% of total), representing the core market. International expansion contributed significantly with Taiwan at 38.9B yen, Suzhou China at 40.1B yen, Thailand at 11.1B yen, and Europe at 14.4B yen. The geographic revenue breakdown by customer location showed Japan at 73.1B yen, Taiwan at 38.9B yen, China at 67.3B yen, and Other regions at 30.2B yen. Cross-border internal sales totaled 57.9B yen, reflecting integrated regional operations. Cost of sales increased to 79.7B yen while maintaining gross margin at 62.0%, indicating stable pricing power and cost management. SG&A expenses rose to 72.3B yen but remained controlled at 34.5% of revenue, down from prior year ratio, contributing to operating leverage. Operating income expanded 26.0% to 57.5B yen with operating margin improving to 27.4% from 25.0% YoY. Non-operating income provided 3.0B yen net benefit, comprising interest income of 0.3B yen, dividend income of 0.3B yen, and FX gains of 2.1B yen. Ordinary income reached 60.5B yen (+29.2% YoY). Extraordinary income of 5.7B yen (nature not detailed) offset extraordinary losses of 1.5B yen, resulting in pre-tax profit of 64.7B yen. Income tax expense of 14.4B yen (effective tax rate 22.3%) led to net income of 57.7B yen, up 64.9% YoY. The extraordinary income contributed approximately 9.0% to pre-tax profit, representing a non-recurring boost. Basic EPS surged 122.4% to 272.14 yen from 122.38 yen, aided by share count reduction from buybacks. This represents a revenue up/profit up pattern with both top-line growth and margin expansion driving profitability improvement.
Japan segment remains the core business with revenue of 135.2B yen (64.5% share) and operating income of 43.0B yen at 31.8% margin, the highest among all segments. Taiwan contributed revenue of 38.9B yen with operating income of 5.1B yen (13.0% margin). Suzhou China generated revenue of 40.1B yen with operating income of 5.6B yen (14.0% margin). Thailand showed improved profitability with revenue of 11.1B yen and operating income of 2.0B yen (18.0% margin). Europe reported revenue of 14.4B yen but minimal operating income of 0.2B yen (1.3% margin), indicating either start-up phase or margin pressure in the region. The Japan segment's margin of 31.8% significantly exceeds other regions, reflecting mature operations, scale advantages, and favorable product mix. Asia segments (Taiwan, China, Thailand) demonstrated mid-to-high teen margins suggesting solid regional profitability. Europe's low 1.3% margin warrants monitoring for improvement or potential restructuring needs. Segment operating income totaled 59.1B yen before inter-segment eliminations of 1.7B yen, reconciling to consolidated operating income of 57.5B yen. The company operates an integrated regional production and sales structure with Japan serving as the hub and overseas subsidiaries functioning as independent business units.
[Profitability] ROE reached 18.9% based on reported data, reflecting strong return on shareholder equity. Operating margin improved to 27.4% from 25.0% YoY, driven by revenue scale and cost control. Net profit margin expanded significantly to 27.5% from 19.2% YoY, aided by non-recurring extraordinary income. Gross profit margin remained stable at 62.0%, indicating sustained pricing power in specialty chemicals. R&D expense totaled 13.8B yen (6.6% of revenue), supporting product innovation. [Cash Quality] Cash and deposits of 103.5B yen cover short-term debt and liabilities 2.2 times, providing ample liquidity buffer. Operating cash flow of 39.8B yen represents 0.69 times net income, indicating some gap between accounting profit and cash generation. Trade receivables increased to 71.7B yen, with DSO extending to 125 days, signaling slower collection cycles. Working capital efficiency shows room for improvement with inventory at 8.2B yen but elevated receivables. [Investment Efficiency] Asset turnover stood at 0.58 times, reflecting the capital-intensive nature of chemical manufacturing. Property, plant and equipment reached 118.5B yen after significant capex of 27.4B yen, representing 3.3 times depreciation expense of 8.2B yen, indicating aggressive capacity expansion. Investment securities totaled 22.1B yen, up 5.9B yen YoY. [Financial Health] Equity ratio strengthened to 83.7% from 81.4% YoY, reflecting conservative capital structure. Current ratio stood at 433.5%, providing substantial short-term solvency. Total liabilities of 59.5B yen remain modest against equity of 304.7B yen, with debt-to-equity ratio of 0.20, among the lowest in manufacturing sectors. Interest-bearing debt is minimal with interest expense of only 0.1B yen. Retained earnings accumulated to 274.3B yen, representing the foundation for shareholder returns.
Operating cash flow of 39.8B yen declined 5.3% YoY despite net income growth of 64.9%, indicating widening gap between earnings and cash generation. The operating CF subtotal before working capital changes was 51.0B yen, but working capital absorbed 11.2B yen primarily from accounts receivable increase of 12.3B yen and accounts payable decrease of 4.6B yen, partially offset by inventory reduction of 0.2B yen. Income taxes paid totaled 17.2B yen. The OCF-to-net-income ratio of 0.69 falls below the healthy threshold of 0.8, warranting attention to receivables management and earnings quality. Investing cash flow of negative 33.9B yen reflected capital expenditures of 27.4B yen, representing 13.1% of revenue and 3.3 times depreciation, signaling capacity expansion phase. Free cash flow totaled 5.8B yen (operating CF minus investing CF), compressed by aggressive capex spending. Financing cash flow of negative 22.5B yen consisted primarily of share buybacks of 12.9B yen and dividend payments. Interest and dividends received contributed 0.6B yen while interest paid remained minimal at 0.1B yen. Cash and deposits increased modestly to 103.5B yen from strong balance sheet base, though free cash flow generation was constrained by investment and shareholder return activities. The cash conversion cycle of 158 days (DSO 125 days plus inventory days minus payable days) highlights working capital intensity requiring management focus.
Ordinary income of 60.5B yen versus operating income of 57.5B yen reflects net non-operating contribution of 3.0B yen, comprising primarily FX gains of 2.1B yen (3.5% of revenue), interest income of 0.3B yen, and dividend income of 0.3B yen. The FX gains represent currency translation benefits from overseas operations and may fluctuate with exchange rate movements, introducing volatility. Extraordinary income of 5.7B yen and extraordinary losses of 1.5B yen resulted in net extraordinary gain of 4.2B yen, contributing 6.5% to pre-tax profit. The nature of extraordinary items was not detailed but represents non-recurring factors that inflated net income growth. Core operating earnings remain robust with operating margin of 27.4%, but the 64.9% YoY net income growth incorporates both operational improvement and one-time gains. Operating cash flow of 39.8B yen relative to net income of 57.7B yen yields an OCF-to-net-income ratio of 0.69, below the healthy 0.8 threshold, raising questions about earnings cash realization. The gap stems from accounts receivable buildup of 12.3B yen and working capital absorption, suggesting revenue growth outpaced collection efficiency. Accruals appear elevated with depreciation of 8.2B yen while capex reached 27.4B yen. Overall earnings quality is adequate with strong core profitability, but investors should monitor the sustainability of FX gains, clarify extraordinary items, and track improvement in cash conversion metrics.
The company forecasts FY2026 revenue of 225.0B yen (+7.4% YoY), operating income of 65.0B yen (+13.1% YoY), and ordinary income of 65.5B yen (+8.2% YoY). Progress rate against full-year forecast cannot be calculated as current results represent full-year FY2025 actuals. The forecasted revenue growth of 7.4% represents moderation from FY2025's 14.9% growth, suggesting return to normalized expansion pace. Operating income growth of 13.1% exceeds revenue growth, implying continued margin expansion through operating leverage. The forecast assumes operating margin improvement to approximately 28.9% from 27.4%, requiring sustained cost discipline. Ordinary income growth of 8.2% lags operating income growth, potentially reflecting normalization of FX gains or non-operating income. The forecast does not appear to incorporate extraordinary gains, focusing on recurring earnings. EPS forecast of 251.91 yen represents a decline from actual FY2025 EPS of 272.14 yen, consistent with extraordinary income normalization. Annual dividend forecast of 40.0 yen implies payout ratio of 15.9% against forecast EPS, maintaining conservative distribution policy. Management commentary notes that forecasts are based on currently available information and reasonable assumptions, with actual results subject to various factors. No specific order backlog data was disclosed for forward revenue visibility assessment. The guidance appears achievable given current momentum, but realization depends on sustained demand, working capital efficiency improvement, and absence of major FX headwinds.
The company declared total annual dividend of 45.0 yen per share, comprising interim dividend of 20.0 yen and year-end dividend of 25.0 yen. Dividend per share increased from 30.0 yen in prior year, representing 50.0% growth aligned with earnings expansion. Payout ratio stood at 36.8% based on dividends against net income, maintaining conservative distribution policy with ample retained earnings for reinvestment. Share buyback activity was significant with 12.9B yen repurchased during the year, reflecting management's confidence in business outlook and commitment to shareholder value. Combined dividends and buybacks resulted in substantial total shareholder returns. Assuming approximately 8.3B yen in dividend payments (45 yen times approximately 184.8 million average shares), total return (dividends plus buybacks) reached approximately 21.2B yen, representing 36.8% of net income as total return ratio. The company maintains 103.5B yen in cash and strong operating cash flow, providing ample capacity to sustain distributions even as free cash flow was constrained to 5.8B yen by aggressive capex. The FY2026 dividend forecast of 40.0 yen represents a 11.1% decrease from FY2025's 45.0 yen, potentially reflecting normalization after extraordinary income boost or shift toward reinvestment priorities. Treasury shares increased to 1,310K shares, reducing outstanding count and supporting per-share metrics. The shareholder return policy balances growth investment with consistent cash distributions, though future buyback pace may moderate to preserve financial flexibility amid expansion initiatives.
Foreign exchange volatility represents a significant risk given FX gains of 2.1B yen contributed 3.5% of ordinary income in FY2025. The company operates across Japan, Taiwan, China, Thailand, and Europe with substantial cross-border transactions and translation exposure. A reversal in favorable currency trends could materially impact profitability, particularly if yen strengthens against Asian currencies. Working capital deterioration poses cash flow risk with DSO extending to 125 days and accounts receivable reaching 71.7B yen (34.2% of revenue). The 12.3B yen YoY receivables increase absorbed cash generation and contributed to OCF-to-net-income ratio of 0.69, below healthy levels. Continued receivables buildup could strain liquidity and signal customer payment challenges or competitive pressure requiring extended payment terms. Capex execution and return realization risk stems from aggressive investment of 27.4B yen (3.3 times depreciation), with construction in progress surging 19.2B yen to 20.5B yen. The company is in major capacity expansion phase, and any delays, cost overruns, or demand shortfalls could impair asset values and depress ROIC. Europe segment generated only 1.3% operating margin on 14.4B yen revenue, warranting turnaround or restructuring. Failure to improve European profitability could drag consolidated margins and raise questions about international expansion strategy.
[Industry Position - Proprietary Analysis] MEC Co., Ltd. operates in the specialty chemicals sector serving electronics manufacturing, particularly printed circuit board (PCB) production. The company's profitability metrics significantly exceed typical industry medians. Operating margin of 27.4% compares favorably against specialty chemical industry median of approximately 12-15%, reflecting niche positioning in high-value electronic materials with technical barriers to entry. ROE of 18.9% substantially exceeds industry median of approximately 10-12%, demonstrating superior capital efficiency and pricing power in specialized applications. Equity ratio of 83.7% ranks in the top tier compared to industry median of 45-55%, indicating exceptionally conservative capital structure with minimal leverage. Net profit margin of 27.5% significantly surpasses industry median of 8-10%, though FY2025 benefited from extraordinary income. The company's gross margin of 62.0% reflects premium product positioning versus commodity chemicals. Revenue growth of 14.9% YoY exceeds industry growth trends of 3-5%, driven by electronics industry expansion and market share gains. Cash conversion metrics show room for improvement with OCF-to-net-income of 0.69 versus industry best practices of above 0.9, primarily due to working capital intensity. Payout ratio of 36.8% aligns with industry norms of 30-40% for mature chemical companies. The company's minimal debt and strong cash position of 103.5B yen provides strategic flexibility rare in capital-intensive manufacturing. Overall, MEC demonstrates industry-leading profitability and financial strength, though working capital efficiency lags best-in-class peers. (Industry: Specialty Chemicals - Electronic Materials, Comparison: FY2024-2025, Source: Proprietary analysis)
MEC demonstrates exceptional profitability with operating margin of 27.4% and ROE of 18.9%, significantly exceeding specialty chemical industry benchmarks, reflecting strong competitive positioning in electronic materials niche serving PCB manufacturing. The fortress balance sheet with 83.7% equity ratio and 103.5B yen cash provides substantial financial flexibility for expansion and shareholder returns, insulating against industry cyclicality. Revenue growth of 14.9% driven by international expansion across Taiwan, China, Thailand, and Europe indicates successful geographic diversification beyond the core Japan market, though Europe segment's 1.3% margin requires improvement. Working capital efficiency represents the primary concern with DSO extending to 125 days and OCF-to-net-income ratio of 0.69, signaling cash conversion challenges despite strong profitability, warranting management attention to receivables and payment term discipline. Aggressive capex of 27.4B yen (3.3 times depreciation) and construction in progress surge to 20.5B yen indicate major capacity expansion underway, with return realization critical to sustaining high ROIC and shareholder value creation. Shareholder returns remain robust with dividend growth to 45 yen per share and 12.9B yen share buybacks, though FY2026 dividend forecast decrease to 40 yen suggests moderation as company prioritizes reinvestment in growth initiatives.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.